ODI PHARMA AB (6OD) — Cash Flow Reinvestment Rate
Latest as of June 2026:
0.00x
ODI PHARMA AB (6OD) has a Cash Flow Reinvestment Rate of 0.00x as of June 2026, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €364.19K. See ODI PHARMA AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
€0.00
Capex + Investments
Operating Cash Flow
€364.19K
EUR
Capital Expenditures
€0.00
EUR
ODI PHARMA AB Cash Flow Reinvestment Rate (2026–2026)
Historical reinvestment intensity for ODI PHARMA AB across 1 annual periods. For the full cash flow conversion analysis, see ODI PHARMA AB cash conversion from operations.
Annual Cash Flow Reinvestment Rate for ODI PHARMA AB (2026–2026)
Year-by-year capital reinvestment analysis for ODI PHARMA AB. See ODI PHARMA AB free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.00x | €0.00 | €4.58 Million | €0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow